Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDrug Development: From Concept to Marketing
Nephron: Clinical Practice, 08/19/09
Nihad AM et al. – Strict regulatory standards govern the conduct of pre–clinical and clinical trials as well as the manufacturing of pharmaceutical products. The assessment of the new medicinal product's safety continues beyond the initial drug approval through post–marketing monitoring of adverse events.
Related Articles
Graffinity Enters into Drug Discovery Research Collaboration with Genentech
b3c newswire, 10/16/09
Relevance Score: 68%
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 66%
The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09
Relevance Score: 66%
Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury
Seminars in Liver Disease, 10/16/09
Relevance Score: 65%
United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
Relevance Score: 65%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor